Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Investment Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Polar Capital Global Healthcare Growth & Income PLC

PCGS:LN

Ticker Delisted

Snapshot for Polar Capital Global Healthcare Growth & Income PLC (PCGS)

Open: - High - Low: - Primary Exchange:
Volume: 0 52-Week Range: - Beta vs UKX: -

ETF Chart for PCGS

No chart data available.
  • PCGS:LN
  • 1M
  • 1Y
0.0000
Interactive PCGS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PCGS

Polar Capital Global Healthcare Growth and Income Trust Plc is an Investment Trust incorporated in the United Kingdom. The Fund's investment objective is to generate capital growth and income by investing in a global portfolio of healthcare stocks.

Inception Date: Telephone: +44-20-7227-2700
Managers: GARETH POWELL / DANIEL MAHONY
Web Site: -

Fundamentals for PCGS

NAV -
Assets (M) -
Shares out (M) 17.80
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for PCGS

No dividends reported

Performance for PCGS

1-Month - 1-Year -
3-Month - 3-Year -
Year To Date - 5-Year -
Expense Ratio -

Top Fund Holdings for PCGS

Filing Date: 12/31/2014
Name Position Value % of Total
Merck & Co Inc 438,507 15,982,800 7.600%
Roche Holding AG 86,330 15,141,600 7.200%
Eli Lilly & Co 327,716 14,510,700 6.900%
AstraZeneca PLC 267,751 12,197,400 5.800%
Novartis AG 178,717 10,725,300 5.100%
Pfizer Inc 498,757 9,884,100 4.700%
AbbVie Inc 221,969 9,253,200 4.400%
Astellas Pharma Inc 834,318 7,570,800 3.600%
Sanofi 125,271 7,360,500 3.500%
Bristol-Myers Squibb Co 160,976 6,098,700 2.900%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil